BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31135077)

  • 1. Molecular characteristics of poorly differentiated chordoma.
    Shih AR; Chebib I; Deshpande V; Dickson BC; Iafrate AJ; Nielsen GP
    Genes Chromosomes Cancer; 2019 Nov; 58(11):804-808. PubMed ID: 31135077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
    Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis.
    Antonelli M; Raso A; Mascelli S; Gessi M; Nozza P; Coli A; Gardiman MP; Arcella A; Massimino M; Buttarelli FR; Giangaspero F
    Am J Surg Pathol; 2017 Jan; 41(1):56-61. PubMed ID: 27635948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
    Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
    Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser P; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Kool M
    Acta Neuropathol; 2016 Jul; 132(1):149-51. PubMed ID: 27067307
    [No Abstract]   [Full Text] [Related]  

  • 8. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
    Feng JY; Chen L; Ma YY; Yang HW; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
    [No Abstract]   [Full Text] [Related]  

  • 10. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.
    Owosho AA; Zhang L; Rosenblum MK; Antonescu CR
    Genes Chromosomes Cancer; 2018 Feb; 57(2):89-95. PubMed ID: 29119645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.
    Bai J; Shi J; Li C; Wang S; Zhang T; Hua X; Zhu B; Koka H; Wu HH; Song L; Wang D; Wang M; Zhou W; Ballew BJ; Zhu B; Hicks B; Mirabello L; Parry DM; Zhai Y; Li M; Du J; Wang J; Zhang S; Liu Q; Zhao P; Gui S; Goldstein AM; Zhang Y; Yang XR
    Nat Commun; 2021 Feb; 12(1):757. PubMed ID: 33536423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of poorly differentiated chordoma.
    Shih AR; Cote GM; Chebib I; Choy E; DeLaney T; Deshpande V; Hornicek FJ; Miao R; Schwab JH; Nielsen GP; Chen YL
    Mod Pathol; 2018 Aug; 31(8):1237-1245. PubMed ID: 29483606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Antonescu CR
    Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1.
    Choy E; MacConaill LE; Cote GM; Le LP; Shen JK; Nielsen GP; Iafrate AJ; Garraway LA; Hornicek FJ; Duan Z
    PLoS One; 2014; 9(7):e101283. PubMed ID: 24983247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of RB1 Gene Copy Number Variations Using a Multiplex Ligation-Dependent Probe Amplification Method.
    Dalay N
    Methods Mol Biol; 2018; 1726():7-18. PubMed ID: 29468539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly differentiated SMARCB1/INI1-negative chordomas.
    Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H
    Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.